Is the measurement of sarcopenia associated with oncological disease in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?
Adrian Hang Yue SiuMatthew HolylandSharon CareyDaniel SteffensNabila AnsariCherry E KohPublished in: ANZ journal of surgery (2023)
Pre-emptive identification of sarcopenia may be a useful prognostic indicator and predictor of post-operative outcomes in CRS and HIPEC. For oncological patients, sarcopenia may be an indicator of patients requiring targeted pre-operative rehabilitation, or advanced disease requiring further treatment.
Keyphrases
- end stage renal disease
- patients undergoing
- chronic kidney disease
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- squamous cell carcinoma
- metabolic syndrome
- patient reported outcomes
- radiation therapy
- acute coronary syndrome
- radical prostatectomy
- drug delivery
- coronary artery bypass
- weight loss
- percutaneous coronary intervention